OptimizeRx (OPRX) Short Interest Ratio & Short Volume $5.45 +0.12 (+2.25%) (As of 11/29/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends OptimizeRx Short Interest DataOptimizeRx (OPRX) has a short interest of 1.06 million shares, representing 6.64% of the float (the number of shares available for trading by the public). This marks a 10.84% increase in short interest from the previous month. The short interest ratio (days to cover) is 5.0, indicating that it would take 5.0 days of the average trading volume of 406,644 shares to cover all short positions.Current Short Interest1,060,000 sharesPrevious Short Interest956,300 sharesChange Vs. Previous Month+10.84%Dollar Volume Sold Short$4.05 millionShort Interest Ratio5.0 Days to CoverLast Record DateNovember 15, 2024Outstanding Shares18,420,000 sharesFloat Size15,960,000 sharesShort Percent of Float6.64%Today's Trading Volume96,484 sharesAverage Trading Volume406,644 sharesToday's Volume Vs. Average24% Short Selling OptimizeRx? Sign up to receive the latest short interest report for OptimizeRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPRX Short Interest Over TimeOPRX Days to Cover Over TimeOPRX Percentage of Float Shorted Over Time Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. OptimizeRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/15/20241,060,000 shares $4.05 million +10.8%6.6%5 $3.83 10/31/2024956,300 shares $4.99 million +4.8%6.0%7.4 $5.22 10/15/2024912,500 shares $5.93 million +8.7%5.8%7.2 $6.50 9/30/2024839,400 shares $6.48 million -2.9%5.3%6.9 $7.72 9/15/2024864,500 shares $6.74 million +0.1%5.4%7.2 $7.80 8/31/2024863,700 shares $7.18 million -8.2%5.4%7.4 $8.31 Get the Latest News and Ratings for OPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter. 8/15/2024941,000 shares $7.90 million +1.0%5.9%7.9 $8.40 7/31/2024931,700 shares $10.16 million -7.8%5.9%7.1 $10.91 7/15/20241,010,000 shares $10.39 million No Change6.4%7.5 $10.29 6/30/20241,010,000 shares $10.10 million -1.0%6.4%7.4 $10.00 6/15/20241,020,000 shares $11.22 million -1.0%6.4%7.3 $11.00 5/31/20241,030,000 shares $12.42 million +12.5%6.4%6.7 $12.06 5/15/2024916,000 shares $12.06 million +12.7%5.7%6 $13.17 4/30/2024812,500 shares $8.29 million +29.7%5.1%6.1 $10.20 4/15/2024626,600 shares $6.47 million -4.5%3.9%5.2 $10.32 3/31/2024656,000 shares $7.97 million -13.1%4.1%5.5 $12.15 3/15/2024754,700 shares $9.58 million -3.3%4.7%6.4 $12.69 2/29/2024780,500 shares $12.36 million +0.3%4.9%5.6 $15.83 2/15/2024778,200 shares $12.38 million -0.1%4.9%5.5 $15.91 1/31/2024778,800 shares $11.00 million -19.6%4.9%4.8 $14.12 1/15/2024968,400 shares $14.31 million +1.3%6.1%5.4 $14.78 12/31/2023956,300 shares $13.68 million -0.1%6.0%5.1 $14.31 12/15/2023957,200 shares $10.56 million -1.0%6.0%5.2 $11.03 11/30/2023967,100 shares $9.20 million +5.0%N/A6.1 $9.51 11/15/2023921,300 shares $8.88 million +5.7%N/A5.2 $9.64 10/31/2023871,400 shares $7.02 million +10.7%N/A4.5 $8.06 10/15/2023787,000 shares $6.68 million +7.6%5.0%4.7 $8.49 9/30/2023731,300 shares $5.69 million +8.1%4.6%5 $7.78 9/15/2023676,600 shares $5.66 million +8.3%4.2%4.7 $8.37 8/31/2023624,800 shares $5.32 million -11.2%3.9%4.6 $8.52 8/15/2023703,200 shares $6.39 million -4.3%4.4%5.6 $9.08 7/31/2023734,600 shares $10.25 million +2.8%4.5%6.9 $13.95 7/15/2023714,700 shares $10.53 million -3.1%4.3%6.3 $14.74 6/30/2023737,900 shares $10.54 million -10.9%4.5%6.1 $14.29 6/15/2023827,700 shares $12.43 million +14.6%5.1%6.2 $15.02 5/31/2023722,100 shares $10.14 million +1.6%4.4%3 $14.04 5/15/2023710,500 shares $9.29 million -19.7%4.3%2.8 $13.08 4/30/2023884,500 shares $13.29 million -3.7%5.4%3.6 $15.03 4/15/2023918,000 shares $13.23 million -14.2%5.6%3.7 $14.41 3/31/20231,070,000 shares $15.65 million -24.7%6.6%4.2 $14.63Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 3/15/20231,420,000 shares $18.37 million -4.7%8.7%5.6 $12.94 2/28/20231,490,000 shares $26.60 million -6.3%9.1%8.2 $17.85 2/15/20231,590,000 shares $29.03 million +3.3%9.7%11 $18.26 1/31/20231,540,000 shares $27.64 million +29.4%9.4%8.7 $17.95 1/15/20231,190,000 shares $22.04 million +3.5%7.3%6.5 $18.52 12/30/20221,150,000 shares $19.32 million +8.5%7.0%6.1 $16.80 12/15/20221,060,000 shares $18.56 million +3.9%6.5%5.4 $17.51 11/30/20221,020,000 shares $21.51 million -9.7%6.2%5.1 $21.09 11/15/20221,130,000 shares $24.91 million +2.7%6.9%5.4 $22.04 10/31/20221,100,000 shares $16.96 million +0.9%N/A4.2 $15.42 10/15/20221,090,000 shares $15.01 million +11.2%6.6%4.1 $13.77 9/30/2022980,000 shares $14.52 million -1.7%5.9%3.5 $14.82 9/15/2022996,800 shares $15.53 million +3.7%6.0%3.6 $15.58 8/31/2022961,500 shares $15.26 million -10.1%6.1%3.7 $15.87 8/15/20221,070,000 shares $16.69 million -12.3%6.7%4.3 $15.60 7/31/20221,220,000 shares $27.41 million -12.9%7.7%6.4 $22.47 7/15/20221,400,000 shares $41.10 million -4.1%8.8%7.1 $29.36 6/30/20221,460,000 shares $39.99 million +13.2%15.2%8.2 $27.39 6/15/20221,290,000 shares $34.31 million +5.7%13.4%7.2 $26.60 5/31/20221,220,000 shares $31.21 million +9.9%7.7%7 $25.58 5/15/20221,110,000 shares $27.88 million -3.5%7.0%6 $25.12 4/30/20221,150,000 shares $32.33 million -17.3%7.2%6.1 $28.11 4/15/20221,390,000 shares $54.13 million -5.4%8.9%7.7 $38.94 3/31/20221,470,000 shares $55.43 million -9.3%9.4%7.4 $37.71 3/15/20221,620,000 shares $59.44 million +14.9%10.4%7.3 $36.69 2/28/20221,410,000 shares $63.86 million +19.5%9.0%5.6 $45.29 2/15/20221,180,000 shares $57.38 million -1.7%7.6%4.5 $48.63 1/31/20221,200,000 shares $53.92 million +0.8%7.7%4.3 $44.93 1/15/20221,190,000 shares $59.12 million -7.0%7.7%4.3 $49.68 12/31/20211,280,000 shares $79.50 million +3.2%8.2%4.9 $62.11 12/15/20211,240,000 shares $68.91 million -15.1%8.0%3.3 $55.57 11/30/20211,460,000 shares $94.90 million -0.7%9.4%4 $65.00 11/15/20211,470,000 shares $117.73 million -13.0%9.5%4.2 $80.09 10/29/20211,690,000 shares $163.42 million -1.7%11.0%5.4 $96.70 10/15/20211,720,000 shares $145.55 million +35.4%11.2%5.4 $84.62 9/30/20211,270,000 shares $108.65 million +19.8%8.3%4.2 $85.55 9/15/20211,060,000 shares $71.00 million -2.8%6.9%6.3 $66.98 8/31/20211,090,000 shares $72.14 million +9.7%7.1%7.3 $66.18 8/13/2021994,100 shares $61.75 million +13.1%6.5%6.7 $62.12 7/30/2021879,000 shares $48.58 million -2.8%5.8%5.7 $55.27 7/15/2021904,400 shares $46.06 million -2.0%6.0%6.1 $50.93 6/30/2021923,200 shares $57.15 million +5.1%6.6%5.8 $61.90 6/15/2021878,500 shares $45.75 million -3.3%5.9%5 $52.08 5/28/2021908,600 shares $44.63 million -3.7%6.1%4.4 $49.12 5/14/2021943,800 shares $40.36 million -3.0%N/A3.9 $42.76 4/30/2021972,800 shares $48.85 million -2.6%N/A3.3 $50.22 4/15/2021999,200 shares $50.16 million -1.1%N/A3.4 $50.20 3/31/20211,010,000 shares $46.84 million +13.9%N/A3.4 $46.38 3/15/2021887,100 shares $40.18 million +1.9%N/A3.1 $45.29 2/26/2021871,000 shares $48.78 million -6.4%N/A3.4 $56.01Watch this before it gets removed (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. 2/12/2021930,300 shares $50.21 million -9.7%N/A4.3 $53.97 1/29/20211,030,000 shares $48.65 million +4.2%8.2%5.5 $47.23 1/15/2021988,900 shares $39.55 million +7.1%7.9%6.3 $39.99 12/31/2020923,400 shares $28.81 million -4.9%7.5%6.1 $31.20 12/15/2020971,000 shares $28.37 million -10.9%7.8%5.7 $29.22 11/30/20201,090,000 shares $27.41 million -7.6%8.8%6.3 $25.15 11/15/20201,180,000 shares $28.74 million -1.7%9.5%7 $24.36 10/30/20201,200,000 shares $24.20 million -3.2%9.7%7.3 $20.17 10/15/20201,240,000 shares $26.90 million +3.3%10.1%7.2 $21.69 9/30/20201,200,000 shares $25.02 million +3.5%9.8%7.4 $20.85 9/15/20201,160,000 shares $23.49 million -3.3%9.6%8.5 $20.25 8/31/20201,200,000 shares $24.19 million -4.0%9.9%8.7 $20.16 8/14/20201,250,000 shares $22 million +21.4%10.3%8.5 $17.60 7/31/20201,030,000 shares $14.57 million +1.0%8.5%7.4 $14.15 7/15/20201,020,000 shares $15.24 million -1.9%8.5%7.7 $14.94 6/30/20201,040,000 shares $13.43 million +22.2%8.7%7.8 $12.91 6/15/2020851,300 shares $10.93 million -4.1%7.1%6.6 $12.84 5/29/2020888,000 shares $10.24 million -0.4%7.4%7.3 $11.53 5/15/2020891,400 shares $8.47 million +1.4%7.4%7.7 $9.50 4/30/2020878,800 shares $8.18 million -1.3%7.3%8.4 $9.31 4/15/2020890,700 shares $8.16 million +2.1%7.4%8.9 $9.16 3/31/2020872,000 shares $8.29 million -4.9%7.3%9.2 $9.51 3/13/2020916,600 shares $7.75 million +11.4%7.8%7.5 $8.46 2/28/2020823,200 shares $5.84 million -4.1%7.0%9 $7.10 2/14/2020858,700 shares $6.22 million +7.7%7.5%10.5 $7.24 1/31/2020797,700 shares $9.01 million +8.7%6.9%8.8 $11.29 1/15/2020734,200 shares $7.80 million -13.2%6.4%6.8 $10.62 12/31/2019845,500 shares $8.64 million -0.5%7.3%7.9 $10.22 OPRX Short Interest - Frequently Asked Questions What is OptimizeRx's current short interest? Short interest is the volume of OptimizeRx shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 1,060,000 shares of OPRX short. 6.64% of OptimizeRx's shares are currently sold short. Learn More on OptimizeRx's current short interest. What is a good short interest ratio for OptimizeRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OPRX shares currently have a short interest ratio of 5.0. Learn More on OptimizeRx's short interest ratio. What is a good short interest percentage for OptimizeRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.64% of OptimizeRx's floating shares are currently sold short. Is OptimizeRx's short interest increasing or decreasing? OptimizeRx saw a increase in short interest in November. As of November 15th, there was short interest totaling 1,060,000 shares, an increase of 10.8% from the previous total of 956,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is OptimizeRx's float size? OptimizeRx currently has issued a total of 18,420,000 shares. Some of OptimizeRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. OptimizeRx currently has a public float of 15,960,000 shares. How does OptimizeRx's short interest compare to its competitors? 6.64% of OptimizeRx's shares are currently sold short. Here is how the short interest of companies in the industry of "business services" compare to OptimizeRx: IBEX Limited (1.07%), CPI Card Group Inc. (1.19%), Absci Co. (13.05%), Accolade, Inc. (4.52%), Resources Connection, Inc. (2.44%), Armlogi Holding Corp. (0.62%), HireQuest, Inc. (2.48%), Perma-Fix Environmental Services, Inc. (6.57%), Nutex Health Inc. (1.21%), Paysign, Inc. (1.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks. What does it mean to sell short OptimizeRx stock? Short selling OPRX is an investing strategy that aims to generate trading profit from OptimizeRx as its price is falling. OPRX shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against OptimizeRx? A short squeeze for OptimizeRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OPRX, which in turn drives the price of the stock up even further. How often is OptimizeRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPRX, twice per month. The most recent reporting period available is November, 15 2024. More Short Interest Resources from MarketBeat Related Companies IBEX Short Squeeze PMTS Short Squeeze ABSI Short Squeeze ACCD Short Squeeze RGP Short Squeeze BTOC Short Squeeze HQI Short Squeeze PESI Short Squeeze NUTX Short Squeeze PAYS Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:OPRX) was last updated on 12/1/2024 by MarketBeat.com Staff From Our PartnersThe latest trend in real estateThese vacation homes are often expensive to maintain and vacant 90% of the year. But thanks to co-ownership, t...Pacaso | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredBofA is watching for a market topU.S. tech stocks have soared so high for so long that they're no longer just minting new millionaires... Th...Chaikin Analytics | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredPaypal, Tesla, SpaceX… Elon's next project is bigger than them allIn February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored***TODAY ONLY*** Is this Trump’s Favorite Coin?Donald Trump just emphatically became America's first crypto president. Trump plans to make America, "the...Weiss Ratings | SponsoredYou’re invited! See my NEWEST trading strategyThis could easily be the most lucrative new trading strategy of 2025... So you’re not going to want to miss...Monument Traders Alliance | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
